Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

NCT04232774 is registered in ClinicalTrials.gov with Neurotronic, Inc. as lead sponsor.

NCT NCT04232774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Lead sponsor
Neurotronic, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2019
Completion date
January 17, 2023
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus with circulatory complciation